ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2298

Fibroblast-driven Ttek Activation May Drive Acinar Cell Dysfunction in Sjögren’s Disease, Prior to Lymphocytic Infiltration

Ting Yang1, Rick Wilbrink1, Janneke Terpstra1, Silvia Liefers2, Arjan Vissink1, Fred Spijkervet1, Hendrika Bootsma3, Frans Kroese4 and Sarah Pringle4, 1UMCG, Groningen, Netherlands, 2University Medical Center Groningen, University of Groningen, Groningen, Groningen, Netherlands, 3Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Groningen, Netherlands, 4University Medical Center Groningen, Groningen, Netherlands

Meeting: ACR Convergence 2024

Keywords: Mitochondrial Dysfunction, Sjögren's syndrome, T-Lymphocyte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Sjögren's Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Lymphocytic infiltration of the salivary glands (SGs) represents one hallmark of the autoimmune conditions Sjögren’s Disease (SjD). It is becoming apparent however that loss of SG function precedes presence of immune infiltration, and that other mechanisms must play a role. We sought to elucidate the earliest events in of SG dysfunction in SjD.

Methods: Parotid gland biopsies were harvested from 12 SSA+ SjD patients grouped into those with no infiltration (focus score (FS) =0, n=4), minimal infiltration (FS 0-1, n=4) and a positive focus score (FS >1, n=4). Healthy control (HC) parotid glands were also harvested (n=4). Single cell RNA sequencing was performed on all cells present in all biopsies. Electron microscopy on SG tissue was performed using standard techniques. Peroxidase-based immunohistochemistry with objective quantification using QuPath software was performed, and 5-plex immunoflourescence using the Opal staining kit. Differentiated SG organoids were generated from healthy SGs using our previously published protocol, exposed to GZMK and analyzed using bulk RNASeq.

Results: In SGs from SjD patients with FS=0, we observed dysregulation of a panel of 12 genes associated with acinar cell functionality. The majority (10/12) of these genes were upregulated in FS=0 SjD patients, compared to HCs.  Upregulation of 3 genes (PRH2, NKCC1 and PIP) was validated at protein level. Mitochondria in acinar cells of FS=0 SjD patients were fewer in number but larger in size compared to HCs. Cellchat analysis of our scRNASeq data suggested that the most likely cell types interacting with each other in FS=0 SGs were fibroblasts as signal producing cells, and CD8+CD69+ Granzyme K+ (GZMK) T cells (‘Ttek’ cells) as signal receiving cells. This interaction was predicted to occur via CXCL12 and extracellular matrix (ECM) components produced by fibroblasts. In tissue of FS=0 SjD patients,  CD69+GZMK+ Tteks, fibroblasts and acinar cells could be located in close proximity to each other. SG organoids  (SGOs) derived from SG progenitor cells can be differentiated into mature SGOs (mSGOs) containing functional acinar cells.  Exposure of mSGOs generated from HC SGs to GZMK induced dysregulation of acinar cell proteins and mitochondria and initiation of an interferon signature.

Conclusion: We hypothesize that activated fibroblasts, in the SGs of patients with SjD before presence of lymphocytic infiltration, promotes activation of tissue resident Ttek cells. The Ttek effector molecule GZMK may then trigger acinar cell dysfunction, and represent the very first stages of SG pathology in SjD.


Disclosures: T. Yang: None; R. Wilbrink: None; J. Terpstra: None; S. Liefers: None; A. Vissink: None; F. Spijkervet: None; H. Bootsma: Argenx, 2, AstraZeneca, 2, 12, Funding, Bristol Myers Squibb, 2, 12, Funding, Galapagos, 2, Novartis, 2, 12, Funding, Roche, 2, 12, Funding, Sanofi, 2, UCB, 2; F. Kroese: None; S. Pringle: None.

To cite this abstract in AMA style:

Yang T, Wilbrink R, Terpstra J, Liefers S, Vissink A, Spijkervet F, Bootsma H, Kroese F, Pringle S. Fibroblast-driven Ttek Activation May Drive Acinar Cell Dysfunction in Sjögren’s Disease, Prior to Lymphocytic Infiltration [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/fibroblast-driven-ttek-activation-may-drive-acinar-cell-dysfunction-in-sjogrens-disease-prior-to-lymphocytic-infiltration/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibroblast-driven-ttek-activation-may-drive-acinar-cell-dysfunction-in-sjogrens-disease-prior-to-lymphocytic-infiltration/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology